Menu
GeneBe

IGFBP1

insulin like growth factor binding protein 1, the group of Insulin like growth factor binding proteins

Basic information

Region (hg38): 7:45888359-45893660

Previous symbols: [ "IBP1" ]

Links

ENSG00000146678NCBI:3484OMIM:146730HGNC:5469Uniprot:P08833AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IGFBP1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGFBP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
16
clinvar
1
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 16 1 0

Variants in IGFBP1

This is a list of pathogenic ClinVar variants found in the IGFBP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-45888732-C-T Hepatocellular carcinoma Pathogenic (Jun 15, 2021)1712930
7-45888770-C-T not specified Uncertain significance (May 25, 2022)2412536
7-45888829-T-G not specified Uncertain significance (Dec 12, 2023)3108599
7-45888855-G-A not specified Uncertain significance (Nov 18, 2022)2328025
7-45888884-T-G Hepatocellular carcinoma Pathogenic (Jun 15, 2021)1713033
7-45888894-G-T not specified Uncertain significance (Feb 10, 2022)2343756
7-45888969-A-C not specified Likely benign (Aug 17, 2021)2351220
7-45888975-C-T not specified Uncertain significance (Feb 27, 2024)3108600
7-45888981-C-A not specified Uncertain significance (Dec 27, 2023)3108601
7-45890551-C-A not specified Uncertain significance (Dec 21, 2023)3108602
7-45890586-A-C not specified Uncertain significance (Aug 02, 2021)2354935
7-45890671-A-G not specified Uncertain significance (Oct 27, 2023)3108603
7-45890680-C-T not specified Uncertain significance (Dec 20, 2022)2337636
7-45891962-G-A not specified Uncertain significance (Oct 28, 2023)3108604
7-45892000-A-T not specified Likely benign (Jun 02, 2024)3285529
7-45892973-T-C not specified Uncertain significance (Feb 15, 2023)2484757
7-45893035-T-A not specified Uncertain significance (Jan 30, 2024)3108605
7-45893038-C-G not specified Uncertain significance (Aug 02, 2021)2240582
7-45893046-C-G not specified Uncertain significance (Oct 20, 2023)3108607
7-45893051-G-T not specified Uncertain significance (Feb 28, 2024)3108608

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IGFBP1protein_codingprotein_codingENST00000275525 45312
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0009470.8211257180111257290.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2531251330.9380.000006431634
Missense in Polyphen3844.340.85701586
Synonymous-0.2166057.91.040.00000304524
Loss of Function1.1569.920.6055.02e-7114

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006200.0000615
Ashkenazi Jewish0.000.00
East Asian0.00005850.0000544
Finnish0.000.00
European (Non-Finnish)0.00001770.0000176
Middle Eastern0.00005850.0000544
South Asian0.0002470.000229
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Promotes cell migration. {ECO:0000269|PubMed:15972819}.;
Pathway
IGF-Ncore;ATF4 activates genes;Aryl Hydrocarbon Receptor Pathway;Vitamin D Receptor Pathway;Nuclear Receptors Meta-Pathway;Myometrial Relaxation and Contraction Pathways;Senescence-Associated Secretory Phenotype (SASP);Photodynamic therapy-induced HIF-1 survival signaling;Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;IGF signaling;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);HIF-1-alpha transcription factor network;FOXA2 and FOXA3 transcription factor networks (Consensus)

Recessive Scores

pRec
0.747

Haploinsufficiency Scores

pHI
0.600
hipred
N
hipred_score
0.258
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.997

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Igfbp1
Phenotype
immune system phenotype; liver/biliary system phenotype; cellular phenotype;

Gene ontology

Biological process
signal transduction;aging;insulin receptor signaling pathway;positive regulation of cell growth;PERK-mediated unfolded protein response;tissue regeneration;regulation of insulin-like growth factor receptor signaling pathway;post-translational protein modification;cellular protein metabolic process;negative regulation of canonical Wnt signaling pathway
Cellular component
extracellular region;extracellular space;endoplasmic reticulum lumen;Golgi apparatus
Molecular function
signaling receptor binding;protein binding;insulin-like growth factor binding;insulin-like growth factor I binding;insulin-like growth factor II binding